The Effects Of Dosage-Controlled Cannabis Capsules On Cancer-Related Cachexia And Anorexia Syndrome In Advanced Cancer Patients: Pilot Study
Notes for this study:
||Three of the patients met the primary endpoint of this study, gaining more than 10% of body weight.
||Uncontrolled / observational study
|Number of Subjects
In this study, 24 participants received either 10 mg of cannabis extract (9.5 mg THC and 0.5 CBD) or placebo, twice daily for six months. If the participants had adverse reactions to the cannabis, their dose was dropped to 5 mg of extract, twice daily.
The primary outcome was body weight, and secondary outcomes were blood markers of metabolic, renal, and liver function and inflammation.
This study had considerable dropout. The entire control group dropped out, and only six of the cannabis group completed the study.